MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)Sacha I. Rothschild, R. Jaggi, Carsten Riether et al.|Journal of Thoracic Oncology|2017Cited by 1